[MeMed in CTech] MeMed raises $93 million to translate the immune system
The Israeli company recently received FDA approval for its MeMed BV test to help healthcare providers distinguish between bacterial and viral infections Read more...
Read MoreJan 10, 2022 | News Center, Newsticker
The Israeli company recently received FDA approval for its MeMed BV test to help healthcare providers distinguish between bacterial and viral infections Read more...
Read MoreDec 1, 2021 | News Center
The winner of AACC’s 2021 Disruptive Technology Award married machine learning and genomics to rapidly identify bloodstream infections. Read more...
Read MoreJul 27, 2021 | News Center
MeMed, a host response-based technologies specialist, has received the CE Mark in Europe for its new disease management solution, MeMed COVID-19 Severity. Read more...
Read MoreJun 18, 2021 | News Center
Bronstein, Zilberberg, Chueiri & Potenza Advogados represented Memed in the transaction. Memed, national leader in digital medical prescriptions, has agreed a contribution of 300 million reais through a fund structured by DNA Capital. Read more...
Read MoreFeb 11, 2021 | News Center, Newsticker
In honor of the International Day of Women and Girls in Science, MeMed’s Dr. Mary Hainrichson offers some words of encouragement. Read more...
Read More